tradingkey.logo

Utah Medical Products Inc

UTMD
59.900USD
+1.175+2.00%
收盤 01/09, 16:00美東報價延遲15分鐘
191.92M總市值
16.91本益比TTM

Utah Medical Products Inc

59.900
+1.175+2.00%

關於 Utah Medical Products Inc 公司

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Utah Medical Products Inc簡介

公司代碼UTMD
公司名稱Utah Medical Products Inc
上市日期Dec 01, 1982
CEOCornwell (Kevin L)
員工數量155
證券類型Ordinary Share
年結日Dec 01
公司地址7043 S 300 West
城市MIDVALE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編84070
電話18015215301
網址http://www.utahmed.com
公司代碼UTMD
上市日期Dec 01, 1982
CEOCornwell (Kevin L)

Utah Medical Products Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-225.00%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--
Mr. Kevin Timken
Mr. Kevin Timken
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-225.00%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Gynecology/Electrosurgery/Urology
4.95M
50.49%
Neonatal
2.18M
22.18%
Blood Pressure Monitoring and Accessories
1.64M
16.74%
Labor & Delivery
1.04M
10.59%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Gynecology/Electrosurgery/Urology
4.95M
50.49%
Neonatal
2.18M
22.18%
Blood Pressure Monitoring and Accessories
1.64M
16.74%
Labor & Delivery
1.04M
10.59%

股東統計

更新時間: 1月8日 週四
更新時間: 1月8日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Brandes Investment Partners, L.P.
10.55%
Renaissance Technologies LLC
6.27%
Dimensional Fund Advisors, L.P.
6.24%
Cornwell (Kevin L)
5.88%
The Vanguard Group, Inc.
5.48%
其他
65.57%
持股股東
持股股東
佔比
Brandes Investment Partners, L.P.
10.55%
Renaissance Technologies LLC
6.27%
Dimensional Fund Advisors, L.P.
6.24%
Cornwell (Kevin L)
5.88%
The Vanguard Group, Inc.
5.48%
其他
65.57%
股東類型
持股股東
佔比
Investment Advisor
41.18%
Investment Advisor/Hedge Fund
19.31%
Hedge Fund
8.74%
Individual Investor
7.14%
Research Firm
0.70%
Bank and Trust
0.18%
Pension Fund
0.05%
Insurance Company
0.04%
其他
22.66%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
245
2.30M
71.70%
-565.83K
2025Q3
243
2.27M
70.80%
-636.90K
2025Q2
249
2.53M
77.79%
-699.23K
2025Q1
251
2.54M
78.08%
-658.65K
2024Q4
245
2.63M
77.47%
-634.89K
2024Q3
233
2.73M
78.80%
-558.16K
2024Q2
224
2.74M
78.05%
-528.35K
2024Q1
214
2.81M
78.59%
-191.73K
2023Q4
203
2.83M
78.07%
-204.85K
2023Q3
194
2.97M
81.82%
-7.55K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Brandes Investment Partners, L.P.
337.93K
10.55%
+4.73K
+1.42%
Sep 30, 2025
Renaissance Technologies LLC
200.91K
6.27%
-12.40K
-5.81%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
200.03K
6.24%
+2.57K
+1.30%
Sep 30, 2025
Cornwell (Kevin L)
188.47K
5.88%
--
--
Mar 03, 2025
The Vanguard Group, Inc.
175.63K
5.48%
-1.47K
-0.83%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
157.18K
4.91%
-744.00
-0.47%
Sep 30, 2025
Hotchkis and Wiley Capital Management, LLC
109.00K
3.4%
-2.95K
-2.63%
Sep 30, 2025
Minerva Advisors LLC
93.06K
2.9%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
89.96K
2.81%
-24.86K
-21.65%
Sep 30, 2025
State Street Investment Management (US)
70.26K
2.19%
+141.00
+0.20%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Acquirers Small and Micro Deep Value ETF
0.89%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
Royce Quant Small-Cap Quality Value ETF
0.2%
WisdomTree U.S. SmallCap Dividend Fund
0.06%
iShares Micro-Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Global X Russell 2000 ETF
0.01%
DFA Dimensional US Small Cap Value ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
查看更多
Acquirers Small and Micro Deep Value ETF
佔比0.89%
JPMorgan Fundamental Data Science Small Core ETF
佔比0.21%
Royce Quant Small-Cap Quality Value ETF
佔比0.2%
WisdomTree U.S. SmallCap Dividend Fund
佔比0.06%
iShares Micro-Cap ETF
佔比0.03%
Avantis US Small Cap Equity ETF
佔比0.02%
Global X Russell 2000 ETF
佔比0.01%
DFA Dimensional US Small Cap Value ETF
佔比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%

分紅派息

近5年累計派現 23.17M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Nov 04, 2025
UTMD.NB Interim Cash Dividend of gross USD 0.31 paid on Jan 05, 2026 going ex on Dec 16, 2025
Dec 16, 2025
Jan 05, 2026
Dec 16, 2025
Jul 29, 2025
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Oct 02, 2025 going ex on Sep 17, 2025
Sep 17, 2025
Oct 02, 2025
Sep 17, 2025
May 08, 2025
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Jul 03, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jul 03, 2025
Jun 16, 2025
Feb 04, 2025
UTMD.NB Final Cash Dividend of gross USD 0.305 paid on Apr 03, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 03, 2025
Mar 14, 2025
Dec 11, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Jan 03, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 03, 2025
Dec 16, 2024
Aug 02, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Oct 04, 2024 going ex on Sep 20, 2024
Sep 20, 2024
Oct 04, 2024
Sep 20, 2024
May 07, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 06, 2024
UTMD.NB Final Cash Dividend of gross USD 0.3 paid on Apr 03, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 03, 2024
Mar 14, 2024
Oct 31, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 03, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 03, 2024
Dec 14, 2023
Aug 02, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Oct 03, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 03, 2023
Sep 14, 2023
查看更多

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Utah Medical Products Inc的前五大股東是誰?

Utah Medical Products Inc的前五大股東如下:
Brandes Investment Partners, L.P.
持有股份:337.93K
佔總股份比例:10.55%。
Renaissance Technologies LLC
持有股份:200.91K
佔總股份比例:6.27%。
Dimensional Fund Advisors, L.P.
持有股份:200.03K
佔總股份比例:6.24%。
Cornwell (Kevin L)
持有股份:188.47K
佔總股份比例:5.88%。
The Vanguard Group, Inc.
持有股份:175.63K
佔總股份比例:5.48%。

Utah Medical Products Inc的前三大股東類型是什麼?

Utah Medical Products Inc 的前三大股東類型分別是:
Brandes Investment Partners, L.P.
Renaissance Technologies LLC
Dimensional Fund Advisors, L.P.

有多少機構持有Utah Medical Products Inc(UTMD)的股份?

截至2025Q4,共有245家機構持有Utah Medical Products Inc的股份,合計持有的股份價值約為2.30M,占公司總股份的71.70% 。與2025Q3相比,機構持股有所增加,增幅為0.90%。

哪個業務部門對Utah Medical Products Inc的收入貢獻最大?

在FY2025Q3,Gynecology/Electrosurgery/Urology業務部門對Utah Medical Products Inc的收入貢獻最大,創收4.95M,占總收入的50.49% 。
KeyAI